Since the enriched NF-κB signaling was dramatically down-regulated and NF-κB/CCL20 axis was previously reported to mediate CRC progression [24, 25], we hypothesized that ABLIM1 accelerates CRC growth and metastasis through modulating NF-κB/CCL20 activation. Here, ABLIM1 is linked to colorectal carcinoma.